BenzingaSeptember 16, 2026 at 4:47 AM NYLast Month
Barclays Upgrades Alvotech to Overweight, Raises Price Target to $8
Barclays analyst Glen Santangelo upgrades Alvotech (NASDAQ:ALVO) from Underweight to Overweight and raises the price target from $4 to $8.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
